The most common kind of surgery used to treat this disease is usually radical prostatectomy which involves the whole prostate being eliminated. Although surgery is very effective it’s likely you’ll experience side effects following this type of treatment. Approximately 70 percent of men encounter some kind of erectile dysfunction post surgery whilst 40 percent experience minor incontinence and 2 percent encounter major incontinence. 4) CHEMOTHERAPY: – This type of treatment entails using medications that eliminate or shrink cancerous cells.Nilotinib can be an orally bioavailable medication with higher potency and selectivity for BCR-ABL than imatinib.8 Nilotinib was first approved in the usa and elsewhere in 2007 for individuals with CML in the chronic or accelerated stage who had resistance to or could not tolerate imatinib. Diagnosis by fluorescence in situ hybridization was not allowed. This is of chronic-stage CML has been described previously.3 Patients needed to have adequate organ function and an Eastern Cooperative Oncology Group performance status of at least 2, which indicates that the individual is with the capacity of all self-care and attention but is unable to carry out any work actions and is out of bed more than 50 percent of waking hours.9 , or any medicine with the potential to prolong the QT interval was prohibited.